Amgen taps Hummingbird’s tech for epitope-based antibody selection

Hummingbird’s method of identifying an antigen’s binding epitopes and screening antibodies has garnered the Singaporean company a new partner in Amgen. The companies revealed Monday that they will discover antibodies against undisclosed targets

Read the full 339 word article

User Sign In